For research use only. Not for therapeutic Use.
Gumelutamide is a tetrahydropyridopyrimidine compound, acting as an antiandrogen, antineoplastic agent. Gumelutamide is an androgen antagonist[1][2].
| Catalog Number | I041944 |
| CAS Number | 1831085-48-3 |
| Synonyms | 2-chloro-4-[4-[[5-(2-hydroxypropan-2-yl)pyridin-2-yl]amino]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]benzonitrile |
| Molecular Formula | C22H21ClN6O |
| Purity | ≥95% |
| InChI | InChI=1S/C22H21ClN6O/c1-22(2,30)15-4-6-20(25-11-15)28-21-17-7-8-29(12-19(17)26-13-27-21)16-5-3-14(10-24)18(23)9-16/h3-6,9,11,13,30H,7-8,12H2,1-2H3,(H,25,26,27,28) |
| InChIKey | TYOPGJVWUJIKHX-UHFFFAOYSA-N |
| SMILES | CC(C)(C1=CN=C(C=C1)NC2=NC=NC3=C2CCN(C3)C4=CC(=C(C=C4)C#N)Cl)O |
| Reference | [1]. Kazuhisa M, et al. Preparation of novel tetrahydropyridopyrimidine compounds, and antiandrogens and antitumor agents containing them: World Intellectual Property Organization, WO2015182712. 2015-12-03. [2]. WHO Drug Information-World Health Organization (WHO). |
